Neuramis Light (with Lidocaine) is a low-viscosity, cross-linked hyaluronic acid gel formulated for subtle skin rejuvenation and correction of fine superficial lines. Intended for delicate areas such as under-eyes (tear troughs), perioral lines and lips, the product provides hydration, improved skin texture and mild contouring with minimal discomfort due to included lidocaine. Supplied as a single-use prefilled 1 mL syringe.
Bnefits
Corrects fine lines and subtly rejuvenates skin surface
Improves skin hydration and elasticity
Suitable for delicate areas (under-eyes, perioral lines, lips)
Includes lidocaine (0.3% w/w) to reduce injection discomfort
Manufactured using SHAPE™ two-step cross-linking technology for gel stability and prolonged effect
Indications
Correction of fine superficial lines (periorbital, perioral, forehead fine lines)
Sterile aqueous gel base and excipients as per manufacturer's IFU
Formulation
Not publicly listed
Packaging
Not publicly listed
Usage
For professional use only — to be administered by trained medical practitioners experienced in dermal filler injections.
Select injection depth and technique appropriate for delicate/superficial areas (micro-bolus, serial puncture, micro-droplet techniques).
Follow aseptic technique and local protocols; tailor volume and placement to individual anatomy.
Provide standard post-treatment aftercare (avoid intense heat, alcohol, strenuous exercise for 24–48 hours).
Keep hyaluronidase available to manage rare adverse events requiring filler dissolution.
Contraindications
Active infection or inflammation at the injection site
Known hypersensitivity to any component (including lidocaine or HA)
History of severe allergies or anaphylaxis
Use in pregnancy or breastfeeding only after clinician risk/benefit assessment
Adverse Effects
Common (usually transient): injection-site swelling, redness, pain, bruising, itching
Less common/serious: infection, nodules/granulomas, hypersensitivity reactions, vascular occlusion (rare; can cause tissue necrosis or visual complications if not promptly treated)
Potential systemic lidocaine effects are unlikely at intended local doses but possible with inadvertent intravascular administration
Storage Conditions
Store in original packaging at 2–25°C; do not freeze.
Protect from excessive heat and direct sunlight.
Shelf life commonly 24 months from manufacture (verify batch IFU/expiry).
Duration
Typical clinical duration approximately 6\u20139 months for superficial indications; longevity varies by treatment area, patient metabolism and technique.
Onset
Immediate visible correction/rehydration after injection; final settling and tissue integration over several days to two weeks.
